| Seliciclib | IC50 | 2400.0 [1] |
| Staurosporine | IC50 | 1.63 [1] |
| Alvocidib | IC50 | 30.0 [1] |
| Olomoucine | IC50 | 7000.0 [1] |
| 6-O-Cyclohexylmethyl guanine | IC50 | 7000.0 [1], 26000.0 [2] |
| 6-O-Cyclohexylmethyl guanine | Ki | 5000.0 [1] |
| Abemaciclib | IC50 | 371.0 [1], 1487.0 [2], 1627.0 [3] |
| Abemaciclib | Ki | 1627.0 [1] |
| Sns-032 | IC50 | 480.0 [1] |
| Kenpaullone | IC50 | 400.0 [1] |
| 4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide | IC50 | 190.0 [1], 200.0 [2] |
| 4-(2,6-Dichlorobenzamido)-N-(piperidin-4-yl)-1H-pyrazole-3-carboxamide | Ki | 190.0 [1] |
| O6-Cyclohexylmethoxy-2-(4'-sulphamoylanilino) purine | IC50 | 9.0 [1], 250.0 [2] |
| Quercetin | IC50 | 20000.0 [1] |
| Palbociclib | IC50 | 10000.0 [1] |
| Palbociclib | Ki | 5000.0 [1] |
| o6-Benzylguanine | IC50 | 24000.0 [1] |
| Indirubin | IC50 | 10000.0 [1], 20000.0 [2] |
| Dinaciclib | IC50 | 3.0 [1], 72.0 [2] |
| Fascaplysin | IC50 | 100000.0 [1], 250000.0 [2] |
| Purvalanol A | IC50 | 4.0 [1], 610.0 [2] |
| 6-Cyclohexylmethyloxy-5-nitroso-pyrimidine-2,4-diamine | IC50 | 2900.0 [1] |
| 6-Butoxy-9H-purin-2-amine | IC50 | 32000.0 [1] |
| Butyrolactonei | IC50 | 600.0 [1] |
| O6-Allylguanine | IC50 | 68000.0 [1] |
| 9H-Purin-2-amine, 6-(2-propyn-1-yloxy)- | IC50 | 91000.0 [1] |
| Purine, 2-amino-6-propoxy- | IC50 | 75000.0 [1] |
| 1H-Purin-2-amine, 6-(1-methylethoxy)- | IC50 | 75000.0 [1] |
| {[(2,6-Difluorophenyl)carbonyl]amino}-N-piperidin-4-yl-1H-pyrazole-3-carboxamide | IC50 | 980.0 [1] |
| 6-Bromo-3-[(3E)-3-(2-piperazin-1-ylethoxyimino)indol-2-yl]-1H-indol-2-ol | IC50 | 200.0 [1], 300.0 [2] |
| 6-Pentoxy-7H-purin-2-amine | IC50 | 37000.0 [1] |
| 9H-Purin-2-amine, 6-(heptyloxy)- | IC50 | 62000.0 [1] |
| 9H-Purin-2-amine, 6-(1-methylpropoxy)- | IC50 | 27000.0 [1] |
| O6-Substituted Guanine Deriv. 11 | IC50 | 21000.0 [1] |
| 9H-Purin-2-amine, 6-(5-hexen-1-yloxy)- | IC50 | 41000.0 [1] |
| O6-Substituted Guanine Deriv. 14 | IC50 | 76000.0 [1] |
| 9H-Purin-2-amine, 6-[(2-methyl-2-propen-1-yl)oxy]- | IC50 | 32000.0 [1] |
| O6-Substituted Guanine Deriv. 17 | IC50 | 19000.0 [1] |
| O6-Substituted Guanine Deriv. 18 | IC50 | 11000.0 [1] |
| O6-Substituted Guanine Deriv. 19 | IC50 | 25000.0 [1] |
| 6-(Cyclopentylmethoxy)-9H-purin-2-amine | IC50 | 15000.0 [1] |
| 9H-Purin-2-amine, 6-(1-cyclopenten-1-ylmethoxy)- | IC50 | 19000.0 [1] |
| 9H-Purin-2-amine, 6-(1-cyclohexen-1-ylmethoxy)- | IC50 | 11000.0 [1] |
| 9H-Purin-2-amine, 6-(3-cyclohexen-1-ylmethoxy)- | IC50 | 6000.0 [1] |
| O6-Substituted Guanine Deriv. 36 | IC50 | 59000.0 [1] |
| O6-Substituted Guanine Deriv. 42 | IC50 | 19000.0 [1] |
| O6-Substituted Guanine Deriv. 48 | IC50 | 39000.0 [1] |
| 6-Bromo-3-[(3E)-3-(2-morpholin-4-ylethoxyimino)indol-2-yl]-1H-indol-2-ol | IC50 | 1100.0 [1], 1800.0 [2] |
| 6-Bromo-3-[(3E)-3-[2-[4-(2-methoxyethyl)piperazin-1-yl]ethoxyimino]indol-2-yl]-1H-indol-2-ol | IC50 | 1000.0 [1], 2800.0 [2] |
| 6-Hydroxy-3-methoxy-4-phenylbenzo[4,3-b]pyridine | IC50 | 64300.0 [1] |
| 6-Hydroxy-3-methoxy-4-phenylbenzo[4,3-b]pyridine | Ki | 5300.0 [1] |
| O6-Substituted Guanine Deriv. 9 | IC50 | 45000.0 [1] |
| 9H-Purin-2-amine, 6-(2-methylbutoxy)- | IC50 | 17000.0 [1] |
| O6-Substituted Guanine Deriv. 30 | IC50 | 37000.0 [1] |
| 3-[2-(5-Fluoro-1-methyl-1H-indol-3-yl)-1,3-thiazol-4-yl]-1-methyl-1H-pyrrolo[2,3-b]pyridine | IC50 | 860.0 [1], 970.0 [2] |
| 6-Bromo-3-[(3E)-3-[2-(dimethylamino)ethoxyimino]indol-2-yl]-1H-indol-2-ol | IC50 | 190.0 [1], 490.0 [2] |
| 8-(4-Methylcyclohexyl)-N-(5-piperazin-1-ylpyridin-2-yl)-4,6,8,11-tetrazatricyclo[7.4.0.02,7]trideca-1(9),2,4,6,10,12-hexaen-5-amine | IC50 | 2660.0 [1], 5200.0 [2] |
| 6-Methoxy-4-phenyl-3-phenylmethoxy-[1]benzofuro[2,3-b]pyridine | Ki | 1000000.0 [1] |
| 7-Methyl-4-phenyl-3-phenylmethoxy-[1]benzofuro[2,3-b]pyridin-6-ol | Ki | 1300.0 [1] |
| 12-Phenyl-13-phenylmethoxy-17-oxa-15-azatetracyclo[8.7.0.02,7.011,16]heptadeca-1(10),2,4,6,8,11,13,15-octaen-8-ol | Ki | 90.0 [1] |
| Imatinib | IC50 | 10000.0 [1] |
| Genistein | IC50 | 370000.0 [1] |
| Baicalein | IC50 | 6530.0 [1] |
| Baicalin | IC50 | 14360.0 [1] |
| Crizotinib | IC50 | 10000.0 [1] |
| 6-Bromoindirubin-3'-oxime | IC50 | 320.0 [1] |
| Doramapimod | IC50 | 30000.0 [1] |
| Purvalanol B | IC50 | 6.0 [1] |
| CID 11612883 | IC50 | 486.0 [1] |
| (5e)-5-(Quinolin-6-Ylmethylidene)-2-[(Thiophen-2-Ylmethyl)amino]-1,3-Thiazol-4(5h)-One | Ki | 35.0 [1] |
| 1-Azakenpaullone | IC50 | 2000.0 [1] |
| Hymenialdisine | IC50 | 22.0 [1] |
| Plinabulin | IC50 | 10100.0 [1] |
| 9H-Purine-2,6-diamine, N2-(2-aminocyclohexyl)-N6-(3-chlorophenyl)-9-ethyl-, cis- | IC50 | 382.0 [1] |
| Milciclib | IC50 | 398.0 [1] |
| Paullone | IC50 | 7000.0 [1] |
| 4-Methyl-5-(2-((4-morpholinophenyl)amino)-pyrimidin-4-yl)thiazol-2-amine | Ki | 10000.0 [1] |
| Pha-793887 | IC50 | 60.0 [1] |
| BS-181 | IC50 | 14000.0 [1] |
| 2-(2-Hydroxyethylamino)-6-(3-chloroanilino)-9-isopropylpurine | IC50 | 340.0 [1] |
| CID 46209401 | IC50 | 790.0 [1] |
| 3-(3-Hydroxy-4-methoxyphenyl)-8h-thieno[2,3-b]pyrrolizin-8-one | IC50 | 5500.0 [1] |
| CID 23643976 | IC50 | 79.0 [1] |
| CID 44219749 | IC50 | 50000.0 [1] |
| Cdk4 Inhibitor | IC50 | 2100.0 [1] |
| RGB-286638 free base | IC50 | 2.0 [1] |
| 4-[(E)-(3,5-Diamino-1h-Pyrazol-4-Yl)diazenyl]phenol | IC50 | 44000.0 [1] |
| 2'-Hydroxy-4'-Methoxychalcone | IC50 | 20000.0 [1] |
| (3-((6-(2-Methoxyphenyl)pyrimidin-4-yl)amino)phenyl)methanesulfonamide | IC50 | 3950.0 [1] |
| Nms-P937 (nms1286937) | IC50 | 10000.0 [1] |
| Voruciclib | IC50 | 25.0 [1] |
| (2S,3S)-3-((7-(Benzylamino)-3-isopropylpyrazolo[1,5-a]pyrimidin-5-yl)amino)butane-1,2,4-triol | IC50 | 33.0 [1] |
| Amg-925 | IC50 | 2220.0 [1] |
| CID 71561915 | Ki | 4.0 [1] |
| 4-[[6-(Ethylamino)-2-[[1-(phenylmethyl)-5-indolyl]amino]-4-pyrimidinyl]amino]-1-cyclohexanol | IC50 | 100000.0 [1] |
| IP3K Inhibitor | IC50 | 100000.0 [1] |
| 2-(3-Hydroxy-4-methoxystyryl)-8-hydroxyquinoline-7-carboxylic acid | IC50 | 10000.0 [1] |
| (3Z)-3-[(3E)-3-(2,3-Dihydroxypropoxyimino)indolin-2-ylidene]indolin-2-one | IC50 | 1650.0 [1] |
| 2,4-Pyrimidinediamine, 5-nitroso-6-(phenylmethoxy)- | IC50 | 27000.0 [1] |
| 8-[2-Methoxy-5-(4-methylpiperazin-1-yl)anilino]-1-methyl-4,5-dihydropyrazolo[4,3-h]quinazoline-3-carboxamide | IC50 | 160.0 [1] |